Loncar Cancer Immunotherapy
$9.02
13
+$0.14+1.58% Tuesday 20:00
Statistics
Day High
9.41
Day Low
9.02
52W High
16.27
52W Low
7.88
Volume
1,978
Avg. Volume
2,180
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Dividends
0%Dividend Yield
Dec 21
$1.85
Jan 21
$0.29
Jan 18
$0.35
Jan 16
$0.11
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CNCR. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index. The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US26922A8264
Listings
0 Comments
Share your thoughts
FAQ
What is Loncar Cancer Immunotherapy stock price today?▼
The current price of CNCR is $9.02 USD — it has increased by +1.58% in the past 24 hours. Watch Loncar Cancer Immunotherapy stock price performance more closely on the chart.
What is Loncar Cancer Immunotherapy stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Loncar Cancer Immunotherapy stocks are traded under the ticker CNCR.
Is Loncar Cancer Immunotherapy stock price growing?▼
CNCR stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Loncar Cancer Immunotherapy has showed a +7.13% increase.
Does Loncar Cancer Immunotherapy pay dividends?▼
Yes, CNCR dividends are paid annual. The last dividend per share was 1.85 USD. As of today, Dividend Yield (FWD)% is 0%.
When did Loncar Cancer Immunotherapy complete a stock split?▼
Loncar Cancer Immunotherapy has not had any recent stock splits.